GSE239844 4 V 5 CRIZOTINIB HUMAN UP (Gene Set)

Analyze

Playbook Workflow Builder
Playbook Workflow Builder: Gene Set Enrichment

Perform Gene Set Enrichment with this gene set against Common Fund program's gene sets, identifying significant overlaps using a pre-built PWB workflow. Run the workflow with GSE239844 4 V 5 CRIZOTINIB HUMAN UP.

GeneSetCart
GeneSetCart

GeneSetCart helps you to fetch gene sets from various data sources, augment, combine with set operations, visualize and analyze these gene sets in a single session. Start a new session with GSE239844 4 V 5 CRIZOTINIB HUMAN UP.

CFDE-GSE
CFDE Gene Set Enrichment (GSE)

CFDE-GSE illuminates connections between the input gene set and various CF gene sets that overlap with the queried gene set. Query CFDE-GSE with GSE239844 4 V 5 CRIZOTINIB HUMAN UP.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with GSE239844 4 V 5 CRIZOTINIB HUMAN UP.

Results found

Linked to

 

Label

Description

 

Gene

H4 clustered histone 15

Gene

ATF7-NPFF readthrough

Gene

corin, serine peptidase

Gene

transient receptor potential cation channel subfamily V member 1

Gene

ADP-ribosylhydrolase like 1

Gene

calcium channel flower domain containing 1

Gene

popeye domain cAMP effector 1

Gene

transmembrane protein adipocyte associated 1

Gene

RAB42, member RAS oncogene family

Gene

storkhead box 2

  • Gene

    H4 clustered histone 15


  • Gene

    ATF7-NPFF readthrough


  • Gene

    corin, serine peptidase


  • Gene

    transient receptor potential cation channel subfamily V member 1


  • Gene

    ADP-ribosylhydrolase like 1


  • Gene

    calcium channel flower domain containing 1


  • Gene

    popeye domain cAMP effector 1


  • Gene

    transmembrane protein adipocyte associated 1


  • Gene

    RAB42, member RAS oncogene family


  • DISPLAY PER PAGE
    This repository is under review for potential modification in compliance with Administration directives.